Literature DB >> 34105830

Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.

Vinod Solipuram1,2, Marina Baretti2, Alexander Y Kim3, Lucy X Chen3, Jill A Fahrner3,4, Meral Gunay-Aygun3, Xiao P Peng3, Dylan Hardenbergh2, Anna Ferguson2, Paige Griffith2, Yuxuan Wang2, Madelena Brancati2, Harish Gopalakrishna1,2, Tomoaki Kato5, Chris Shubert2, Daniel Laheru2, Mark Yarchoan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34105830      PMCID： PMC9472764          DOI： 10.1002/hep.31998

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  2 in total

1.  Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.

Authors:  Janice Cho; Joy C Y Chen; Jonas Paludo; Erin E Conboy; Brendan C Lanpher; Steven R Alberts; Thorvardur R Halfdanarson
Journal:  J Gastrointest Oncol       Date:  2019-06

2.  A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.

Authors:  Rodrigo C Surjan; Elizabeth S Dos Santos; Tiago Basseres; Fabio F Makdissi; Marcel A Machado
Journal:  Am J Case Rep       Date:  2017-03-08
  2 in total
  2 in total

1.  Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma.

Authors:  Xiaoyuan Chen; Yiwei Lu; Xiaoli Shi; Guoyong Han; Long Zhang; Chuangye Ni; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 2.  A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects.

Authors:  Georgios Polychronidis; Anastasia Murtha-Lemekhova; Juri Fuchs; Evdokia Karathanasi; Katrin Hoffmann
Journal:  Onco Targets Ther       Date:  2022-10-03       Impact factor: 4.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.